SLC5A2 and hydrops fetalis: Dapagliflozin remains beneficial for patients with HF, even for those treated with sacubitril-valsartan.54 However, neprilysin and SGLT2 inhibition represent distinct mechanisms in the pathophysiology pathways of HF.55